Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer

Sara M Tolaney, Zefei Jiang, Qingyuan Zhang, Romualdo Barroso-Sousa, Yeon Hee Park, Mothaffar F Rimawi, Cristina Saura, Andreas Schneeweiss, Masakazu Toi, Yee Soo Chae, Yasemin Kemal, Mukesh Chaudhari, Mehmet A N Şendur, Toshinari Yamashita, Monica Casalnuovo, Michael A Danso, Jie Liu, Jagdish Shetty, Pia Herbolsheimer, Sibylle Loibl; DESTINY-Breast09 Trial Investigators

The New England Journal of Medicine, 2025 Oct. 29

Link all’abstract

Forse può anche interessarti